SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001370053-23-000069
Filing Date
2023-11-27
Accepted
2023-11-27 16:17:25
Documents
14
Period of Report
2023-11-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K anab-20231124.htm   iXBRL 8-K 26993
2 EX-99.1 cbs004pressrelease.htm EX-99.1 16699
  Complete submission text file 0001370053-23-000069.txt   218411

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20231124.xsd EX-101.SCH 2177
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20231124_def.xml EX-101.DEF 8934
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20231124_lab.xml EX-101.LAB 33136
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20231124_pre.xml EX-101.PRE 20656
8 EXTRACTED XBRL INSTANCE DOCUMENT anab-20231124_htm.xml XML 2817
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 231440449
SIC: 2834 Pharmaceutical Preparations